Poly(ADP-ribose) polymerase-1 and its ambiguous role in cellular life and death

被引:6
作者
Castedo, Maria [1 ,2 ]
Lafarge, Antoine [1 ,2 ,3 ]
Kroemer, Guido [1 ,2 ,4 ]
机构
[1] Sorbonne Univ, Univ Paris Cite, Ctr Rech Cordeliers, Equipe 11 Labellisee Ligue Canc,INSERM U1138, F-75006 Paris, France
[2] Metabol & Cell Biol Platforms, Gustave Roussy Canc Campus, Villejuif, France
[3] Univ Paris Saclay, Fac medecine, Le Kremlin Bicetre, France
[4] Hop Europeen Georges Pompidou, Assistance Publ Hop Paris, Inst Canc Paris CARPEM, Dept Biol, Paris, France
关键词
PARP1; inhibition; DNA damage; parthanatos; cancer; neurological diseases; aging; cellular stress response; PARP; INHIBITION; NECROSIS; MITOCHONDRIAL; ACTIVATION; CISPLATIN; APOPTOSIS; ELEGANS;
D O I
10.15698/cst2023.01.275
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The deletion of the gene coding for poly(ADP-ribose) polymerase-1 (PARP1) or its pharmacological inhi-bition protects mice against cerebral ischemia and Parkin-son's disease. In sharp contrast, PARP1 inhibitors are in clinical use for the eradication of vulnerable cancer cells. It appears that excessive PARP1 activation is involved in a specific cell death pathway called parthanatos, while inhi-bition of PARP1 in cancer cells amplifies DNA damage to a lethal level. Hence, PARP1 plays a context-dependent role in cell fate decisions. In addition, it appears that PARP1 plays an ambiguous role in organismal aging.
引用
收藏
页码:1 / 6
页数:6
相关论文
共 45 条
[1]   NAD+ Metabolism in Cardiac Health, Aging, and Disease [J].
Abdellatif, Mahmoud ;
Sedej, Simon ;
Kroemer, Guido .
CIRCULATION, 2021, 144 (22) :1795-1817
[2]   Mitochondrial and Nuclear Cross Talk in Cell Death Parthanatos [J].
Andrabi, Shaida A. ;
Dawson, Ted M. ;
Dawson, Valina L. .
MITOCHONDRIA AND OXIDATIVE STRESS IN NEURODEGENERATIVE DISORDERS, 2008, 1147 :233-241
[3]   Poly(ADP-ribosyl)ation and aging [J].
Bürkle, A ;
Beneke, S ;
Muiras, ML .
EXPERIMENTAL GERONTOLOGY, 2004, 39 (11-12) :1599-1601
[4]   PARP inhibition enhances tumor cell-intrinsic immunity in ERCC1-deficient non-small cell lung cancer [J].
Chabanon, Roman M. ;
Muirhead, Gareth ;
Krastev, Dragomir B. ;
Adam, Julien ;
Morel, Daphne ;
Garrido, Marlene ;
Lamb, Andrew ;
Henon, Clemence ;
Dorvault, Nicolas ;
Rouanne, Mathieu ;
Marlow, Rebecca ;
Bajrami, Ilirjana ;
Cardenosa, Marta Llorca ;
Konde, Asha ;
Besse, Benjamin ;
Ashworth, Alan ;
Pettitt, Stephen J. ;
Haider, Syed ;
Marabelle, Aurelien ;
Tutt, Andrew N. J. ;
Soria, Jean-Charles ;
Lord, Christopher J. ;
Postel-Vinay, Sophie .
JOURNAL OF CLINICAL INVESTIGATION, 2019, 129 (03) :1211-1228
[5]   The multifaceted roles of PARP1 in DNA repair and chromatin remodelling [J].
Chaudhuri, Arnab Ray ;
Nussenzweig, Andre .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2017, 18 (10) :610-621
[6]   PARP Inhibitors and Myeloid Neoplasms: A Double-Edged Sword [J].
Csizmar, Clifford M. ;
Saliba, Antoine N. ;
Swisher, Elizabeth M. ;
Kaufmann, Scott H. .
CANCERS, 2021, 13 (24)
[7]   Poly(ADP-ribose) polymerase inhibition: past, present and future [J].
Curtin, Nicola J. ;
Szabo, Csaba .
NATURE REVIEWS DRUG DISCOVERY, 2020, 19 (10) :711-736
[8]   PJ34 Protects Photoreceptors from Cell Death by Inhibiting PARP-1 Induced Parthanatos after Experimental Retinal Detachment [J].
Dong, Kai ;
Yan, Yuanye ;
Lu, Li ;
Wang, Yisai ;
Li, Jinping ;
Zhang, Mei ;
Ding, Jie .
CURRENT EYE RESEARCH, 2021, 46 (01) :115-121
[9]   Poly(ADP-Ribose) Polymerase Is Hyperactivated in Homologous Recombination-Defective Cells [J].
Gottipati, Ponnari ;
Vischioni, Barbara ;
Schultz, Niklas ;
Solomons, Joyce ;
Bryant, Helen E. ;
Djureinovic, Tatjana ;
Issaeva, Natalia ;
Sleeth, Kate ;
Sharma, Ricky A. ;
Helleday, Thomas .
CANCER RESEARCH, 2010, 70 (13) :5389-5398
[10]   Poly(ADP-ribose) Polymerase (PARP) is Critically Involved in Liver Ischemia/reperfusion-injury [J].
Haga, Sanae ;
Kanno, Akira ;
Morita, Naoki ;
Jin, Shigeki ;
Matoba, Kotaro ;
Ozawa, Takeaki ;
Ozaki, Michitaka .
JOURNAL OF SURGICAL RESEARCH, 2022, 270 :124-138